Delivery Order SPE2DB24D3013-SPE2DB24FFGYW

Award Date 8/14/24
Potential Completion Date 8/15/24
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $16,489.96 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of GARDASIL 9 syringes, a vaccine product, to support military treatment programs and facilities. The contract has an ultimate completion date of July 30, 2024 and is a firm fixed-price arrangement. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $13,394.37 contract is for the delivery of GARDASIL 9 vaccine syringes to support military treatment programs and facilities. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, which has a total...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $34,721.57 firm fixed-price contract is for the supply of GARDASIL 9 SYRINGE 10S, a vaccine product, with a performance period through August 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,768.51, is for the delivery of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $87,459.30 Firm Fixed Price contract is for the procurement of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of December 18, 2023 and was awarded on December 15, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This is a $38,444.34 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product, with a period of performance through April 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,587.65, is for the delivery of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The order has an ultimate completion date of March 13, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,606.42, is for the delivery of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has a firm fixed price pricing type and an ultimate completion date of November 16, 2023. This delivery order is a component of a larger Indefinite Delivery Contract (IDC) valued...
This is a $19,782.56 firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of GARDASIL 9 syringes, a vaccine product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999, which enables the DLA to efficiently procure a wide range of medical commodities from AmerisourceBergen to support...
This is a $32,096.81 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of GARDASIL 9 vaccine syringes. The contract has a period of performance through February 4, 2025 and is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999. The IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB24FFGYW
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $16,389.76 firm-fixed-price contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The delivery order was issued under an Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical for providing a wide range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. There is no set-aside designation for this contract award, and the ultimate completion date is August 15, 2024.

Generated 11/13/24, 9:15 AM